JP2001204470A - Method for promptly screening bacterium gene and kit therefor - Google Patents
Method for promptly screening bacterium gene and kit thereforInfo
- Publication number
- JP2001204470A JP2001204470A JP2000056490A JP2000056490A JP2001204470A JP 2001204470 A JP2001204470 A JP 2001204470A JP 2000056490 A JP2000056490 A JP 2000056490A JP 2000056490 A JP2000056490 A JP 2000056490A JP 2001204470 A JP2001204470 A JP 2001204470A
- Authority
- JP
- Japan
- Prior art keywords
- pcr
- bacterial
- bacteria
- dna
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 241000894006 Bacteria Species 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 15
- 238000012216 screening Methods 0.000 title abstract 6
- 230000001580 bacterial effect Effects 0.000 claims abstract description 17
- 238000003745 diagnosis Methods 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 108700003860 Bacterial Genes Proteins 0.000 claims abstract description 8
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 8
- 208000019206 urinary tract infection Diseases 0.000 claims abstract description 6
- 230000003211 malignant effect Effects 0.000 claims abstract description 4
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 3
- 230000035945 sensitivity Effects 0.000 claims abstract description 3
- 210000002700 urine Anatomy 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 11
- 239000012085 test solution Substances 0.000 claims description 7
- 201000011510 cancer Diseases 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 238000012163 sequencing technique Methods 0.000 claims description 5
- 238000000018 DNA microarray Methods 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 230000002496 gastric effect Effects 0.000 claims description 4
- 238000010998 test method Methods 0.000 claims description 4
- 210000001635 urinary tract Anatomy 0.000 claims description 4
- 206010017964 Gastrointestinal infection Diseases 0.000 claims description 2
- 230000036210 malignancy Effects 0.000 claims description 2
- 230000002068 genetic effect Effects 0.000 claims 3
- BUNGCZLFHHXKBX-UHFFFAOYSA-N 8-methoxypsoralen Natural products C1=CC(=O)OC2=C1C=C1CCOC1=C2OC BUNGCZLFHHXKBX-UHFFFAOYSA-N 0.000 claims 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 claims 1
- 208000019836 digestive system infectious disease Diseases 0.000 claims 1
- 229960004469 methoxsalen Drugs 0.000 claims 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 230000014670 detection of bacterium Effects 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 14
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 8
- 241000894007 species Species 0.000 description 6
- 206010016952 Food poisoning Diseases 0.000 description 5
- 208000019331 Foodborne disease Diseases 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000013382 DNA quantification Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、PCR法を応用し
て便または尿、あるいは食品類を検体とし、迅速に細菌
遺伝子を検査する方法及びキットに関するものである。
更に詳しくは、細菌遺伝子による菌種同定を、細菌培養
を行うことなくDNA検出を利用してPCR法を応用
し、便または尿を検体として迅速に細菌悪性細胞遺伝子
を、あるいは食品類を検体として迅速に細菌遺伝子を検
査方法及びキットに関する。TECHNICAL FIELD The present invention relates to a method and kit for rapidly testing bacterial genes using stool, urine, or food as a sample by applying the PCR method.
More specifically, bacterial species identification using bacterial genes, PCR is applied using DNA detection without bacterial culture, and stool or urine is used as a sample to quickly detect bacterial malignant cell genes or foods as samples. The present invention relates to a method and a kit for rapidly testing bacterial genes.
【0002】[0002]
【従来の技術】消化管感染症または尿路感染症などの感
染症の診断は、便あるいは尿を検体とし、該検体から菌
を分離培養した後、得られた菌集落を検鏡、染色、PC
R法などの方法で確認することによって行われている。2. Description of the Related Art Diagnosis of infectious diseases such as gastrointestinal tract infection and urinary tract infection is performed by using stool or urine as a specimen, separating and culturing the bacteria from the specimen, and then examining the colonies obtained by microscopy and staining. PC
The confirmation is performed by a method such as the R method.
【0003】また、消化管または尿路悪性腫瘍の診断で
は、採取した便あるいは尿を検体として該検体から細胞
を遠心分離などの方法で回収後、検鏡して細胞の形態学
的な性状により判定されている。In the diagnosis of gastrointestinal or urinary tract malignant tumors, collected stool or urine is used as a specimen, and cells are collected from the specimen by centrifugation or the like. Has been determined.
【0004】食品を発生源とする食品中毒が発生した場
合には採取した食品から菌を分離培養した後、得られた
菌集落を検鏡、染色、PCR法などの方法で確認するこ
とが行われている。[0004] In the case of food poisoning originating from foods, bacteria are separated and cultured from the collected foods, and the resulting bacterial colonies are confirmed by methods such as microscopy, staining, and PCR. Have been done.
【0005】[0005]
【発明が解決しようとする課題】消化管または尿路感染
症を、患者の便または尿を検体として採取し、細菌を分
離培養し、得られた菌集落を検鏡、染色、PCR法など
の方法で確認する診断方法は、検査に1日〜7日を要す
るだけでなく細菌の分離培養には高度な専門的知識と技
術を必要とし、外来患者を待たせて病状を判定出来るも
のではなかった。The gastrointestinal tract or urinary tract infection is collected from a patient's stool or urine as a specimen, the bacteria are separated and cultured, and the resulting bacterial colonies are examined by microscopy, staining, PCR, etc. The diagnostic method confirmed by the method not only requires 1 to 7 days for the test, but also requires a high level of specialized knowledge and technology for the isolation and cultivation of bacteria, and does not allow outpatients to wait and determine the disease state. Was.
【0006】また、高度な専門的知識と技術を必要とす
る細菌の分離培養を行わずに検体に直接PCR法を適用
する方法も開発されているが、この方法でも検体の便あ
るいは尿に遠心分離、熱変性処理などの処理を行い、細
菌から遺伝子を抽出後にPCR法を行っているので少な
くとも3〜4時間を要し、迅速な診断とは言えない。[0006] A method has also been developed in which the PCR method is applied directly to a sample without performing the separation and culture of bacteria requiring high specialized knowledge and technology. However, even in this method, centrifugation is performed on the stool or urine of the sample. Since a process such as separation and heat denaturation is performed, and a PCR method is performed after extracting a gene from the bacterium, it requires at least 3 to 4 hours, which is not a quick diagnosis.
【0007】消化管または尿路悪性腫瘍の診断は、検体
から細胞を遠心分離などの方法で回収後、検鏡して細胞
の形態学的な性状により判定する方法で行われているの
で該判定には時間だけでなく極めて専門的な技術を必要
とし、診断には熟練を要した。[0007] Diagnosis of a gastrointestinal tract or urinary tract malignant tumor is performed by collecting cells from a specimen by a method such as centrifugation, and then performing microscopic examination to determine the morphological properties of the cells. Required not only time but also extremely specialized skills, and diagnosis required skill.
【0008】上述の様なことから、患者から採取した便
あるいは尿を検体として、極めて短時間に、また、高度
な専門的技術を必要とせずに消化管または尿路感染症や
悪性腫瘍を迅速に診断する方法の開発が待たれていた。[0008] From the above, the stool or urine collected from a patient can be used as a sample to rapidly diagnose gastrointestinal or urinary tract infections and malignant tumors in a very short time and without requiring advanced technical skills. The development of a diagnostic method was awaited.
【0009】食品中毒の場合には、発生源の確定や菌の
同定は緊急を要する問題であり、極めて短時間に、正確
に菌を確定する技術の開発が待たれていた。In the case of food poisoning, determination of the source and identification of bacteria are urgent issues, and development of a technique for accurately determining bacteria in an extremely short time has been awaited.
【0010】[0010]
【課題を解決するための手段】迅速診断または食品中毒
菌の迅速同定と言う課題を解決するために発明者らは鋭
意研究の結果、微量な細菌遺伝子を、PCR法を応用し
て迅速に検出し、感染症や悪性腫瘍診断の一助とする画
期的な検査方法及び食品中の細菌を迅速に同定する検査
方法を開発するに至った。Means for Solving the Problems In order to solve the problem of rapid diagnosis or rapid identification of food poisoning bacteria, the present inventors have conducted intensive studies, and as a result, a small amount of bacterial genes can be quickly detected by applying the PCR method. As a result, they have developed a revolutionary test method to help diagnose infectious diseases and malignant tumors and a test method for rapidly identifying bacteria in foods.
【0011】本発明は、高感度で高速反応性のあるDN
Aポリメラーゼ、細菌遺伝子検出用プライマー及び細菌
のDNAを抽出することなくPCRを可能としたPCR
緩衝液を必須成分とし、8−Methoxypsora
lenを添加して検査液となし、紫外線処理を行った
後、該検査液に患者から採取した便あるいは尿を直接添
加してPCRを行って細菌遺伝子を検出するもので、細
菌の分離培養や菌体からのDNAの抽出、定量作業を省
略することにより、遺伝子の人為的な喪失がなくなるだ
けでなく、作業者の習熟度による結果変動がない。The present invention relates to a highly sensitive and highly reactive DN.
A polymerase, primers for detecting bacterial genes, and PCR that enables PCR without extracting bacterial DNA
8-Methoxypropyla with buffer as an essential component
After adding len to make a test solution and performing an ultraviolet ray treatment, stool or urine collected from a patient is directly added to the test solution and PCR is performed to detect a bacterial gene. By omitting the extraction and quantification of DNA from the cells, not only is there no artificial loss of the gene, but also the result does not fluctuate due to the skill of the operator.
【0012】本発明では検体から細菌の検出を行う場合
にはDNAポリメラーゼ内に混入している大腸菌DNA
を除去する目的で検査液に8−Methoxypsor
alenを添加して紫外線ランプを用いてソラレン・紫
外線処理を約2分間行い、続いてPCRを行うが、細菌
由来の遺伝子を検出する場合以外にはソラレン・紫外線
処理を行う必要がない。In the present invention, when bacteria are detected from a specimen, Escherichia coli DNA contaminated in DNA polymerase is used.
8-Methoxysorbor to test solution for the purpose of removing
The psoralen / ultraviolet ray treatment is performed for about 2 minutes using an ultraviolet lamp with the addition of alen, followed by PCR. However, there is no need to perform the psoralen / ultraviolet ray treatment except for detecting a gene derived from bacteria.
【0013】本発明の特徴の一つである、高感度、高速
PCRを行うためのDNAポリメラーゼとしては宝酒造
(株)製のTAKARA z−TaqDNAポリメラー
ゼが有用であり、また、細菌からDNAの抽出作業を行
うことなくPCRを可能としたPCR緩衝液としては
(株)島津製作所製のSHIMADZU Ampdir
ectが有用であるが、本発明はそれに限定されるもの
ではない。As a DNA polymerase for performing high-sensitivity, high-speed PCR, which is one of the features of the present invention, TAKARA z-Taq DNA polymerase manufactured by Takara Shuzo Co., Ltd. is useful. As a PCR buffer solution that enables PCR without performing the above, SHIMADZU Ampdir manufactured by Shimadzu Corporation
ect is useful, but the invention is not so limited.
【0014】本発明は、検体から遺伝子の抽出を行うこ
となく直接PCR法に供することが可能なため、検査開
始から1時間以内で判定出来る。Since the present invention can be directly subjected to the PCR method without extracting a gene from a specimen, the determination can be made within one hour from the start of the test.
【0015】また、本発明では目的とする菌に特異的な
PCRプライマーを設定して、該プライマーに反応する
か否かで判定を行うので高度な専門的技術を必要とする
ことなく、迅速に、正確に診断を行うことが出来る。Further, in the present invention, a PCR primer specific to a target bacterium is set, and the determination is made based on whether or not the primer reacts with the primer. The diagnosis can be made accurately.
【0016】本発明を従来から一般的に行われている細
菌遺伝子を応用した診断方法と比較すると、従来法で
は、便あるいは尿から採取した細菌の分離培養に1乃至
3日、DNA抽出に2乃至5時間、DNA定量に10乃
至20分、PCRに2乃至3時間、電気泳動に10乃至
15分を要した。When the present invention is compared with a conventional diagnosis method using a bacterial gene, the conventional method requires 1 to 3 days for separating and culturing bacteria collected from stool or urine, and 2 days for DNA extraction. DNA quantification took 10 to 20 minutes, PCR took 2 to 3 hours, and electrophoresis took 10 to 15 minutes.
【0017】食品中毒を発生した食品を検体とする、食
品中の細菌検査の場合も便あるいは尿を検体とする場合
とほぼ同程度の所要時間を要した。[0017] In the case of a bacterial test in a food in which a food that has caused food poisoning is used as a specimen, the same time is required as in the case of using stool or urine as a specimen.
【0018】これに対して本発明では、ソラレン・紫外
線処理に2分、PCRに30乃至40分、電気泳動に1
0乃至15分と非常に時間短縮が可能となる。On the other hand, in the present invention, 2 minutes for psoralen / ultraviolet ray treatment, 30 to 40 minutes for PCR, and 1 minute for electrophoresis
The time can be greatly reduced to 0 to 15 minutes.
【0019】PCR終了後、電気泳動を省略し、PCR
産物をエチジウムブロマイドやSYBRグリーンなどの
色素で直接染色して比色することにより、判定すること
も可能である。また、パーキンエルマー社製などのリア
ルタイム定量PCRシステムを組み合わせてPCR施行
中に同時判定をすることも可能となる。After completion of the PCR, the electrophoresis is omitted, and the PCR
It is also possible to judge the product by directly staining it with a dye such as ethidium bromide or SYBR green and colorimetrically. It is also possible to make a simultaneous determination during the execution of PCR by combining a real-time quantitative PCR system such as that manufactured by PerkinElmer.
【0020】更に、細菌の検出を行う場合には高感度、
高速PCRを可能とするために使用されるDNAポリメ
ラーゼである、z−TaqDNAポリメラーゼ内に混入
している大腸菌DNAを除去するためにソラレン・紫外
線処理が必要であるが、細菌以外の検体の場合には不要
なので、一層、迅速な検査が可能となる。Further, when detecting bacteria, high sensitivity is required.
A psoralen / ultraviolet ray treatment is required to remove Escherichia coli DNA contaminating z-Taq DNA polymerase, which is a DNA polymerase used to enable high-speed PCR. Is unnecessary, so that a quicker inspection is possible.
【0021】検出された細菌の詳細な種類を正確かつ迅
速に判定する場合には、PCRで増幅した遺伝子の塩基
配列を、塩基配列決定法あるいはDNAチップを用いて
検査することによって細菌の正確な菌種同定が出来る。In order to accurately and promptly determine the type of the detected bacteria, the exact sequence of the bacteria can be determined by examining the nucleotide sequence of the gene amplified by PCR using a nucleotide sequencing method or a DNA chip. Bacterial species can be identified.
【0022】[0022]
【実施例】以下、本発明を実施例にて具体的に説明する
が、本発明は実施例に限定されるものではない。EXAMPLES Hereinafter, the present invention will be described specifically with reference to examples, but the present invention is not limited to the examples.
【0023】[0023]
【実施例1】滅菌処理をしたプラスチックチューブに下
記の溶液を作製した。 滅菌蒸留水 23μl Ampdirect A液 10μl Ampdirect I液 10μl DNTP(10mM) 4μl 8−Methoxypsoralen液(2.5mg/mlDMSO) 0.5μl z−TaqDNAポリメラーゼ(5U/μl) 0.5μl 上記の溶液に365nmの紫外線を1cmの距離から2
分間照射する。次に細菌検出用ユニバーサルプライマー
(10pmol/μl)としてセンスプライマーとアン
チセンスプライマーの各々1μlを添加して検査液とし
た。Example 1 The following solutions were prepared in sterilized plastic tubes. Sterile distilled water 23 μl Ampdirect A solution 10 μl Ampdirect I solution 10 μl DNTP (10 mM) 4 μl 8-Methoxypropylen solution (2.5 mg / ml DMSO) 0.5 μl z-Taq DNA polymerase (5 U / μl) From a distance of 1 cm to 2
Irradiate for minutes. Next, 1 μl of each of a sense primer and an antisense primer was added as a universal primer (10 pmol / μl) for bacterial detection to prepare a test solution.
【0024】採取した便に対して約2〜10倍量の生理
食塩水あるいはトリス−EDTA緩衝液あるいはナトリ
ウム−燐酸−EDTA緩衝液などを加えて攪拌し、静置
法、遠心分離法、濾紙・フィルターによる濾過法などの
方法で不純物を除去後、その約1μlを前記検査液に添
加して試験検体を作製した。該試験検体をサーマルサイ
クラーに設置し、98℃/1秒、68℃/10秒のPC
Rプロトコールを30回実行した。About 2 to 10 times the volume of physiological saline, Tris-EDTA buffer or sodium-phosphate-EDTA buffer, etc. is added to the collected stool and stirred, and the mixture is allowed to stand, centrifuge, filter paper, or the like. After removing impurities by a method such as filtration using a filter, about 1 μl thereof was added to the test solution to prepare a test sample. The test sample was placed in a thermal cycler and a 98 ° C / 1 second, 68 ° C / 10 second PC
The R protocol was run 30 times.
【0025】尿を検体とする場合には遠心分離して沈殿
物を採取し、該沈殿物を直接あるいは約2〜10倍量の
生理食塩水あるいはトリス−EDTA緩衝液あるいはナ
トリウム−燐酸−EDTA緩衝液などで希釈後、その約
1μlを用いて便を検体とする場合と同様の操作を行っ
た。When urine is used as a sample, the precipitate is collected by centrifugation, and the precipitate is directly or about 2 to 10 times the volume of physiological saline, Tris-EDTA buffer or sodium-phosphate-EDTA buffer. After dilution with a liquid or the like, the same operation as in the case where stool was used as a sample was performed using about 1 μl of the solution.
【0026】PCRした試験検体の8μlを採取し、エ
チジウムブロマイド含有1%アガロースゲルで100V
/15分間の電気泳動を行った。電気泳動終了後のゲル
に紫外線を照射し、エチジウムブロマイドで染色された
遺伝子のバンドを観察し、バンドの出現したものを陽性
と判定した。8 μl of the test sample subjected to PCR was collected, and 100 V was applied to a 1% agarose gel containing ethidium bromide.
/ 15 minutes electrophoresis was performed. The gel after the electrophoresis was irradiated with ultraviolet light, the band of the gene stained with ethidium bromide was observed, and the appearance of the band was determined to be positive.
【0027】[0027]
【実施例2】採取した食品に2〜10倍量の生理食塩水
を加え、ミキサーで攪拌、粉砕した後、静置法、遠心分
離法、または濾過法によって不純物を除去して検体と
し、その約1μlを実施例1で作製した検査液に添加し
て試験検体を作製した。Example 2 A 2 to 10 times volume of physiological saline was added to the collected food, stirred and crushed with a mixer, and impurities were removed by a static method, a centrifugal method, or a filtration method to obtain a sample. About 1 μl was added to the test solution prepared in Example 1 to prepare a test sample.
【0028】[0028]
【実施例3】細菌の菌種を同定するために、本発明の方
法で増幅したPCR産物を直接シークエンス反応に用い
て該細菌の塩基配列を決定した。また、本発明の方法の
PCR溶液中にシークエンスプライマーを加え、増幅反
応とシークエンス反応を同時に行い、所要時間の短縮を
可能とした。Example 3 In order to identify the species of bacteria, the nucleotide sequence of the bacteria was determined by directly using the PCR product amplified by the method of the present invention in a sequencing reaction. In addition, a sequencing primer was added to the PCR solution of the method of the present invention, so that the amplification reaction and the sequencing reaction were performed simultaneously, thereby making it possible to reduce the required time.
【0029】[0029]
【実施例4】DNAチップを用いて細菌の菌種を同定す
るために、各菌種に特異的なプローブを必要数だけDN
Aチップ上に固定し、本発明の方法で増幅したPCR産
物をDNAチップ上にハイブリダイズ反応させた。PC
R産物とハイブリダイズしたプローブが菌種と同定され
た。Example 4 In order to identify bacterial species using a DNA chip, a necessary number of probes specific to each bacterial species were used in DNs.
The PCR product immobilized on the A chip and amplified by the method of the present invention was subjected to a hybridization reaction on the DNA chip. PC
The probe hybridized with the R product was identified as a bacterial species.
【0030】[0030]
【発明の効果】本発明は、便あるいは尿、または食品を
検体とし、そこに存在する内在性あるいは外来性の細胞
や細菌遺伝子を、その抽出操作なしに迅速に検出するも
のであり、その結果、消化管感染症または尿路感染症の
診断、消化管または尿路悪性腫瘍の診断、または食品を
仲介する食品中毒の細菌検査を迅速に、確実に行うこと
を可能とした。According to the present invention, stool, urine, or food is used as a specimen, and endogenous or exogenous cells or bacterial genes present therein are detected rapidly without the extraction operation. The present invention has made it possible to rapidly and reliably perform diagnosis of gastrointestinal tract infection or urinary tract infection, diagnosis of gastrointestinal tract or urinary tract malignancy, or bacterial testing of food-mediated food poisoning.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 大島 譲二 埼玉県熊谷市久保島1785−2 Fターム(参考) 4B024 AA13 AA20 HA20 4B063 QA01 QA13 QA18 QQ03 QQ42 QQ52 QR08 QR62 QS02 QS25 QX01 ────────────────────────────────────────────────── ─── Continued on the front page (72) Inventor Joji Oshima 1785-2 Kuboshima, Kumagaya-shi, Saitama F-term (reference) 4B024 AA13 AA20 HA20 4B063 QA01 QA13 QA18 QQ03 QQ42 QQ52 QR08 QR62 QS02 QS25 QX01
Claims (4)
高感度で高速PCRを可能とするDNAポリメラーゼ、
細菌遺伝子検出用プライマー及びDNAを抽出すること
なくPCRを可能とするPCR用緩衝液を必須成分とし
て8−Methoxypsoralenを添加し、紫外
線処理してなる検査液に添加してPCRを行うことを特
徴とする、PCR法を応用した迅速で直接的な細菌遺伝
子検査法及びキット。A stool or urine is used as a sample, and the sample is directly
DNA polymerase that enables high sensitivity and high speed PCR,
PCR is carried out by adding 8-methoxypsoralen as an essential component, a primer for detecting bacterial genes and a PCR buffer capable of performing PCR without extracting DNA, and adding the resultant to a test solution obtained by ultraviolet treatment. A rapid and direct bacterial genetic test method and kit using the PCR method.
求項1に記載の迅速で直接的な細菌遺伝子検査法及びキ
ット。2. The rapid and direct bacterial genetic test method and kit according to claim 1, wherein the sample is a food.
は尿路悪性腫瘍の診断を迅速に行うことを特徴とする請
求項1に記載の迅速で直接的な細菌悪性細胞遺伝子検査
法及びキット。3. The method of claim 1, wherein the diagnosis of gastrointestinal or urinary tract infection or gastrointestinal or urinary tract malignancy is rapidly performed. kit.
を、塩基配列決定法あるいはDNAチップを用いて検査
し、細菌の詳細な種類を決定することを特徴とする迅速
で直接的な細菌悪性細胞遺伝子検査法及びキット。4. A rapid and direct bacterial malignant cell, characterized by examining the nucleotide sequence of the gene amplified by the PCR using a nucleotide sequencing method or a DNA chip to determine a detailed type of bacteria. Genetic testing methods and kits.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000056490A JP2001204470A (en) | 2000-01-27 | 2000-01-27 | Method for promptly screening bacterium gene and kit therefor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000056490A JP2001204470A (en) | 2000-01-27 | 2000-01-27 | Method for promptly screening bacterium gene and kit therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001204470A true JP2001204470A (en) | 2001-07-31 |
Family
ID=18577427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000056490A Pending JP2001204470A (en) | 2000-01-27 | 2000-01-27 | Method for promptly screening bacterium gene and kit therefor |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001204470A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014127806A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Dna amplifying kit |
| WO2014127804A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Pathogen diagnosis system |
| WO2014127805A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Diagnosis method of pathogen |
-
2000
- 2000-01-27 JP JP2000056490A patent/JP2001204470A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014127806A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Dna amplifying kit |
| WO2014127804A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Pathogen diagnosis system |
| WO2014127805A1 (en) | 2013-02-19 | 2014-08-28 | Daiken Medical Co., Ltd. | Diagnosis method of pathogen |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102535489B1 (en) | Method for detecting and characterising a microorganism | |
| US20200149120A1 (en) | Sample nucleic acid measurement test kit, reagent, and application thereof | |
| JPH03133379A (en) | Extraction of nucleic acid without using protein decomposing enzyme and pcr augmenting method | |
| CN115029459A (en) | Kit for visually detecting Pasteurella multocida based on CRISPR-Cas12a and application | |
| EP3212792B1 (en) | Nucleic acid modifying agents and uses thereof | |
| CN108410951B (en) | A new nucleic acid extraction reagent and its application | |
| WO2010102460A1 (en) | A method and kit for quantitative and qualitative detection of genetic material of pathogenic microorganisms | |
| CN111518877B (en) | One-tube method nest type real-time quantitative PCR detection kit for detecting echinococcus multilocularis and echinococcus granulosus by parting trace samples | |
| US20220098645A1 (en) | Fast and portable microfluidic detection system as an alternative to salmonella's classical culture method | |
| CN114196766A (en) | Molecular marker, primer pair, kit and method for specifically identifying rice bacterial blight Xoo | |
| CN110607398B (en) | RT-LAMP kit for fluorescent visual rapid detection of porcine epidemic diarrhea virus | |
| WO2021179469A1 (en) | Composition for detecting pathogens, and kit and method therefor | |
| CN111254226A (en) | Primer group, fluorescence visualization RT-LAMP kit and method for rapidly detecting canine distemper virus | |
| JP6318239B2 (en) | Method for extracting fungal nucleic acid | |
| JP2001204470A (en) | Method for promptly screening bacterium gene and kit therefor | |
| JP4510222B2 (en) | Bacteria identification method | |
| CN107460249A (en) | A kind of primer, probe and kit for being used to detect methicillin-resistant staphylococcus aureus drug resistant gene | |
| CN108034721B (en) | Fusion gene oligonucleotide for detecting leukemia NUP98 series, detection method and kit | |
| JP2001169778A (en) | Method and kit for rapidly testing bacterial gene | |
| CN112342317A (en) | Nucleic acid sequence combination, kit and detection method for LAMP-CRISPR (loop-mediated isothermal amplification-CRISPR) isothermal detection of IHHNV (infectious bronchitis Virus) | |
| CN113512598A (en) | Real-time fluorescent nucleic acid isothermal amplification detection kit for Bacillus pertussis and its special primers and probes | |
| CN110964849A (en) | A method for eliminating false positives of African swine fever virus detection and kit for detecting African swine fever virus | |
| RU2814548C1 (en) | Test system for detecting dna of causative agent of mannheimiosis (mannheimia haemolytica) in biological material of animals and fodders using real-time polymerase chain reaction | |
| RU2814556C1 (en) | Test system for detecting dna of causative agent of moraxellosis kpc (moraxella bovis) in biological material of animals and feed using polymerase chain reaction in real time | |
| CN102776275B (en) | A kind of primer set and its kit for visual detection of Mycobacterium tuberculosis |